The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy

Journal of ECT

Volumn 22, Issue 3, 2006, Pages 184-188

  Khalid, Najeeb ^a   Atkins, Maria ^a   Kirov, George ^b  

^a CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

ECT; Etomidate; Seizure; Thiopental

Indexed keywords

ETOMIDATE; THIOPENTAL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; ELECTROSTIMULATION; FEMALE; HUMAN; MALE; SEIZURE THRESHOLD;

AGED; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; ETOMIDATE; FEMALE; HUMANS; MALE; MIDDLE AGED; SEIZURES; THIOPENTAL; TIME FACTORS;

EID: 33748591363     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/01.yct.0000235931.24032.15     Document Type: Article

References (28)

1. Devanand DP, Sackeim HA, Prudic J. Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am. 1991;14:905-923.
2. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am. 1991;14:350-355.
3. Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980 and 1986. Am J Psychiatry. 1994;151:1657-1661.
4. Maletzky BM. Seizure duration and clinical effect in electroconvulsive therapy. Compr Psychiatry. 1978;19:541-550.
5. Delva NJ, Brunet D, Hawken ER, et al. Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. J ECT. 2000;16:361-369.
6. Freeman CP. The ECT Handbook. London, UK: Royal College of Psychiatrists; 1995.
7. Scott AIF. The ECT Handbook. London, UK: Royal College of Psychiatrists; 2005.
8. Weiner RD, Coffey CE, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am. 1991;14:845-870.
9. Sackeim H, Decina P, Prohovnik I, et al. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry. 1987;44:355-360.
10. Gaines GY, Rees DI. Electroconvulsive therapy and anesthetic considerations. Anesth Analg. 1986;16:157-170.
11. Martensson B, Bartfai A, Hallen B, et al. A comparison of propofol and methohexital as anesthetic agents for ECT: effects on seizure duration, therapeutic outcome, and memory. Biol Psychiatry. 1994;35:179-189.
12. Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81:596-602.
13. Freeman CP. Anesthesia for electroconvulsive therapy. Statement from the Royal College of Psychiatrists Special Committee for electroconvulsive therapy. Psychiatr Bull. 1999;23:740-741.
14. Kovac AL, Pardo M. A comparison between etomidate and methohexitone for anaesthesia in ECT. Convuls Ther. 1992;8:118-125.
15. Trzepacz PT, Weniger FC, Greenhouse J. Etomidate anesthesia increases seizure duration during ECT. A retrospective study. Gen Hosp Psychiatry. 1993;15:115-120.
16. Gazdag G, Kocsis N, Tolna J, et al. Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. J ECT. 2004;20:225-229.
17. Grati L, Louzi M, Nasr K, et al. Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy. Presse Med. 2005;34:282-284.
18. Gran L, Bergsholm P, Bleie H. Seizure duration in unilateral electroconvulsive therapy: a comparison of the anaesthetic agents etomidate and althesin with methohexitone. Acta Psychiatr Scand. 1984;69:472-483.
19. Saffer S, Berk M. Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone. J ECT. 1998;14:89-93.
20. Conca A, Germann R, Konig P. Etomidate vs. thiopentone in electroconvulsive therapy: an interdisciplinary challenge for anesthesiology and psychiatry. Pharmacopsychiatry. 2003;36:94-97.
21. Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology. 1984;6:647-651.
22. Crozier TA, Beck D, Schlaeger M, et al. Endocrinological changes following etomidate, midazolam, or methohexital for minor surgery. Anesthesiology. 1987;66:628-635.
23. Preziosi P, Vacca M. Adrenocortical suppression and other endocrine effects of etomidate. Life Sci. 1988;42:477-489.
24. American Psychiatric Association Task Force on ECT. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association; 2001.
25. Christensen P, Kragh-Sorensen P, Sorensen C, et al. EEG-monitored ECT: a comparison of seizure duration under anesthesia with etomidate and thiopentone. Convuls Ther. 1986;2:145-150.
26. Ilivicky H, Caroff S, Simone AF. Etomidate during ECT for elderly seizure-resistant patients. Am J Psychiatry. 1995;152:957-958.
27. Hansen HC, Drenck NF. Generalised seizures after etomidate anaesthesia. Anaesthesia. 1988;43:805-806.
28. Duthie DJ, Fraser R, Nimo WS. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth. 1985;57:156-159.